250 related articles for article (PubMed ID: 31475740)
1. A snapshot of intralesional verapamil injection in the treatment of Peyronie's disease today.
Sadagopan A
Andrologia; 2019 Nov; 51(10):e13388. PubMed ID: 31475740
[TBL] [Abstract][Full Text] [Related]
2. Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
Asali M; Asali M
Arch Ital Urol Androl; 2020 Oct; 92(3):. PubMed ID: 33016057
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
[TBL] [Abstract][Full Text] [Related]
4. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
Rehman J; Benet A; Melman A
Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
[TBL] [Abstract][Full Text] [Related]
5. Intralesional verapamil for the treatment of Peyronie's disease: a review.
Levine LA; Estrada CR
Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
[TBL] [Abstract][Full Text] [Related]
7. Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.
Shirazi M; Haghpanah AR; Badiee M; Afrasiabi MA; Haghpanah S
Int Urol Nephrol; 2009; 41(3):467-71. PubMed ID: 19199072
[TBL] [Abstract][Full Text] [Related]
8. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
Greenfield JM; Shah SJ; Levine LA
J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
[TBL] [Abstract][Full Text] [Related]
9. Intralesional verapamil injection for the treatment of Peyronie's disease.
Levine LA; Merrick PF; Lee RC
J Urol; 1994 Jun; 151(6):1522-4. PubMed ID: 8189561
[TBL] [Abstract][Full Text] [Related]
10. Experience with intraplaque injection of verapamil for Peyronie's disease.
Levine LA; Goldman KE; Greenfield JM
J Urol; 2002 Aug; 168(2):621-5; discussion 625-6. PubMed ID: 12131321
[TBL] [Abstract][Full Text] [Related]
11. Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease: A Systematic Review of the Literature.
Russo GI; Milenkovic U; Hellstrom W; Levine LA; Ralph D; Albersen M
Eur Urol; 2018 Dec; 74(6):767-781. PubMed ID: 30237020
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
[TBL] [Abstract][Full Text] [Related]
13. Intralesional verapamil prevents the progression of Peyronie's disease.
Bennett NE; Guhring P; Mulhall JP
Urology; 2007 Jun; 69(6):1181-4. PubMed ID: 17572211
[TBL] [Abstract][Full Text] [Related]
14. Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease.
Mehrsai AR; Namdari F; Salavati A; Dehghani S; Allameh F; Pourmand G
Andrology; 2013 Jan; 1(1):129-32. PubMed ID: 23258641
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of intralesional injection of verapamil in treatment of Peyronie's disease.
Heidari M; Nejadi JR; Ghate A; Delfan B; Iran-Pour E
J Pak Med Assoc; 2010 Apr; 60(4):291-3. PubMed ID: 20419973
[TBL] [Abstract][Full Text] [Related]
16. Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study.
Favilla V; Russo GI; Privitera S; Castelli T; Madonia M; La Vignera S; Condorelli R; Calogero AE; Farina FP; Cimino S; Morgia G
Andrologia; 2014 Oct; 46(8):936-42. PubMed ID: 24124921
[TBL] [Abstract][Full Text] [Related]
17. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
18. [Clinical effects of verapamil in the treatment of Peyronie's disease].
Arena F; Peracchia G; Di Stefano C; Passari A; Larosa M; Cortellini P
Acta Biomed Ateneo Parmense; 1995; 66(6):269-72. PubMed ID: 8928594
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Management of Peyronie's Disease.
Trost LW; Gur S; Hellstrom WJ
Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
[TBL] [Abstract][Full Text] [Related]
20. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study.
Jordan GH
J Sex Med; 2008 Jan; 5(1):180-7. PubMed ID: 18173766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
